SIROLIMUS

12660 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking SIROLIMUS:

# Side effect Count
0 OFF LABEL USE 1893
1 DRUG INEFFECTIVE 1053
2 PRODUCT USE IN UNAPPROVED INDICATION 762
3 PYREXIA 500
4 DIARRHOEA 493
5 PNEUMONIA 464
6 ACUTE KIDNEY INJURY 424
7 DRUG INTERACTION 416
8 THROMBOTIC MICROANGIOPATHY 364
9 TRANSPLANT REJECTION 355
See all common reactions for SIROLIMUS

SIROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COW POX 9 0.8182
1 STAPHYLOCOCCAL MEDIASTINITIS 10 0.4545
2 SKIN SQUAMOUS CELL CARCINOMA METASTATIC 25 0.2688
3 AVIAN INFLUENZA 14 0.2258
4 FOCAL GLOMERULOSCLEROSIS 22 0.2075
5 SMOOTH MUSCLE CELL NEOPLASM 73 0.1968
6 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 10 0.1923
7 SKIN GRAFT REJECTION 9 0.1636
8 INFERIOR VENA CAVA STENOSIS 8 0.1633
9 PROPIONIBACTERIUM INFECTION 16 0.1495
See all enriched reactions for SIROLIMUS